US20120190854A1 - Hydroamination of Alkenes - Google Patents

Hydroamination of Alkenes Download PDF

Info

Publication number
US20120190854A1
US20120190854A1 US13/440,465 US201213440465A US2012190854A1 US 20120190854 A1 US20120190854 A1 US 20120190854A1 US 201213440465 A US201213440465 A US 201213440465A US 2012190854 A1 US2012190854 A1 US 2012190854A1
Authority
US
United States
Prior art keywords
group
nmr
mhz
cdcl
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/440,465
Inventor
Akihiro Takemiya
Zhijian Liu
John F. Hartwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois filed Critical University of Illinois
Priority to US13/440,465 priority Critical patent/US20120190854A1/en
Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT reassignment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
Publication of US20120190854A1 publication Critical patent/US20120190854A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2442Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems
    • B01J31/2447Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring
    • B01J31/2452Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring with more than one complexing phosphine-P atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/60Preparation of compounds containing amino groups bound to a carbon skeleton by condensation or addition reactions, e.g. Mannich reaction, addition of ammonia or amines to alkenes or to alkynes or addition of compounds containing an active hydrogen atom to Schiff's bases, quinone imines, or aziranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/324Cyclisations via conversion of C-C multiple to single or less multiple bonds, e.g. cycloadditions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/822Rhodium

Definitions

  • Alkylamines are among the most common functional groups in pharmaceuticals.
  • the hydroamination of alkenes is one of the simplest and most atom-economical methods to prepare alkylamines, and much effort has now been spent to develop catalysts for such additions of amines to alkenes.
  • activated alkenes include alkenes in strained ring systems, such as norbornenes, which have been subjected to hydroamination catalyzed by complexes of transition metals such as iridium (A. L. Casalnuovo et al. J. Am. Chem. Soc. 110, 6738, 1988; R. Dorta et al. J. Am. Chem. Soc. 119, 10857, 1997).
  • Examples of activated alkenes also include vinyl arenes, which have been subjected to hydroamination catalyzed by complexes of transition metals such as rhodium (Beller, M. et al. Eur.
  • alkenes such as vinyl arenes, 1,3-dienes, acrylates and acrylonitriles have been subjected to hydroamination catalyzed by complexes of transition metals such as iron, cobalt, nickel, ruthenium, rhodium, palladium, osmium, iridium, and platinum (Kawatsura, M. et al. J. Am. Chem. Soc. 122, 9546, 2000; O. Löber et al. J. Am. Chem. Soc. 123, 4366, 2001; Utsunomiya, M. et al. J. Am. Chem. Soc.
  • alkylamines It would be desirable to transform unactivated alkenes into alkylamines in a way that is relatively insensitive to air and moisture. It would also be desirable to provide alkylamines from substrates that include one or more functional groups in addition to the alkene group. Ideally, such a system would provide alkylamines from terminal or internal alkenes, using primary or secondary amino groups.
  • the invention provides a method including reacting an amino group, a composition including rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture.
  • R 1 is an organic group including a sp 3 carbon atom bonded to C A .
  • R 2 is selected from the group consisting of hydrogen, methyl, and an organic group including a sp 3 carbon atom bonded to C A .
  • R 3 and R 4 independently are selected from the group consisting of hydrogen, methyl, and an organic group including a sp 3 carbon atom bonded to C B .
  • the method further includes forming a hydroaminated product in the reaction mixture.
  • the invention provides a composition including rhodium, and an organic ligand selected from the group consisting of 4,5-(bis[bis-diethylamido]-phosphonito)-9,9-dimethylxanthene, 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl, and substituted derivatives of these.
  • the invention provides a catalyst including rhodium and an organic ligand.
  • a catalyst including rhodium and an organic ligand.
  • group means a linked collection of atoms or a single atom within a molecular entity, where a molecular entity is any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.
  • a group is any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.
  • the description of a group as being “formed by” a particular chemical transformation does not imply that this chemical transformation is involved in making the molecular entity that includes the group.
  • organic group means a group containing at least one carbon atom.
  • amino group means a group formed by removing a hydrogen from ammonia (NH 3 ), from the nitrogen of a primary amine compound (RNH 2 ) or from the nitrogen of a secondary amine compound (R′R′′NH), where R, R′ and R′′ are organic groups.
  • a primary amino group may be represented by the structural formula —NH 2
  • a secondary amino group may be represented by the structural formula —NRH.
  • alkene means an acyclic or cyclic compound consisting entirely of hydrogen atoms and carbon atoms, and including at least one carbon-carbon double bond.
  • An alkene may be substituted with one or more substituent groups, which may include atoms other than carbon and hydrogen.
  • substituted group means a group that replaces one or more hydrogen atoms in a molecular entity.
  • substituent groups include halide groups, alkyl groups, heteroalkyl groups, aryl groups, and heteroaryl groups.
  • substituted derivative means a compound in which one or more hydrogen atoms has been replaced with a substituent group.
  • complex means a molecular entity including a central metal atom, to which is associated a surrounding array of other groups of atoms, referred to as “ligands.”
  • ligand when referring to a distinct substance, means an organic compound that can be associated to a metal atom when combined with the metal atom.
  • sp 3 carbon atom means a carbon atom that is bonded to four other atoms through individual single bonds.
  • heterocyclic group means a group formed by removing a hydrogen from a ring atom of a heterocyclic compound, where a heterocyclic compound is a cyclic compound having as ring members carbon and at least one other element.
  • Heterocyclic groups include heterocycloalkyl groups, heteroaryl groups, and mixtures of these.
  • a heterocyclic group may be monocyclic or polycyclic and may be substituted with one or more substituent groups.
  • the term “functional group” means a group that includes atoms other than hydrogen and sp 3 carbon atoms, and that has similar chemical properties when it occurs in different organic compounds.
  • Examples of functional groups include hydroxyl (—OH), protected hydroxyl, ether (—C—O—C—), ketone (>C ⁇ O), ester (—C( ⁇ O)O—C‘), carboxylic acid (—C( ⁇ O)OH), cyano (—C ⁇ N), amido (—C( ⁇ O)NH—C—), protected amino, thiol (—SH), sulfone, sulfoxide, phosphine, phosphite, phosphate, and halide (—X).
  • FIG. 1 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate 2,2-diphenylpent-4-en-1-amine (1).
  • FIG. 2 represents a reaction scheme for a generic example of the hydroamination of FIG. 1 .
  • FIG. 3 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate N- ⁇ 4-[(2,2-diphenylpent-4-enylamino)methyl]benzyl ⁇ -2,2-diphenylpent-4-en-1-amine.
  • the present invention makes use of the discovery that amines can be added to unactivated alkenes using a composition that includes a rhodium complex. These hydroaminations are mild and can proceed with high yields. Both primary and secondary amines may be added to the alkene.
  • alkene substrates may be used, including 1,1- and 1,2-disubstituted alkenes and alkenes that include other functional groups.
  • a method may include reacting an amino group, a composition including rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture.
  • R 1 is an organic group including a sp 3 carbon atom bonded to C A .
  • R 2 is hydrogen, methyl, or an organic group including a sp 3 carbon atom bonded to C A .
  • R 3 and R 4 independently are hydrogen, methyl, or an organic group including a sp 3 carbon atom bonded to C B .
  • the reaction mixture may include a solvent, and may include other ingredients.
  • the method further includes forming a hydroaminated product in the reaction mixture.
  • the substrate includes a carbon-carbon double bond, represented in formula (I) as C A ⁇ C B .
  • carbon C A is bonded either to two sp 3 carbon atoms, or to hydrogen and a sp 3 carbon atom.
  • carbon C B is bonded to two hydrogens, to two sp 3 carbon atoms, or to hydrogen and a sp 3 carbon atom.
  • each of R 2 , R 3 and R 4 may be hydrogen, such that the double bond is mono-substituted.
  • R 2 is methyl or an organic group including a sp 3 carbon atom bonded to C A
  • R 3 and R 4 are hydrogen, such that the double bond is 1,1 di-substituted.
  • R 2 is hydrogen, and one of R 3 and R 4 is methyl or an organic group including a sp 3 carbon atom bonded to C B , such that the double bond is 1,2 di-substituted.
  • the substrate may include at least one functional group.
  • functional groups in the substrate can hinder or prevent the desired addition of the amino group.
  • the substrate may include at least one functional group such as hydroxyl (—OH), protected hydroxyl, ether (—O—C—), ketone (>C ⁇ O), ester (—C( ⁇ O)O—C—), carboxylic acid (—C( ⁇ O)OH), cyano (—C ⁇ N), amido (—C( ⁇ O)NH—C—), protected amino, thiol (—SH), sulfone, sulfoxide, phosphine, phosphite, phosphate, halide (—X), and combinations of these.
  • the amino group may be a primary amino group (—NH 2 ) or a secondary amino group (—NRH, where R is an organic group).
  • the compound for which the amino group is a substituent may be, for example, an alkane, a heteroalkane, an alkene, a heteroalkene, or an aromatic compound.
  • the compound may include one or more other substituent groups.
  • the amino group is a substituent of an alkane or a heteroalkane.
  • the amino group may be present as part of a compound separate from the substrate, or it may be present as part of the substrate. If the amino group is a substituent group of another compound, separate from the substrate, then a hydroamination reaction between the amino group and the carbon-carbon double bond is an intermolecular reaction. In contrast, if the amino group is a substituent group of the substrate, then a hydroamination reaction between the amino group and the carbon-carbon double bond is an intramolecular reaction.
  • the hydroaminated product includes a carbon-carbon single bond (C A -C B ) in place of the carbon-carbon double bond (C A ⁇ C B ), and includes an amino group bonded to one of C A and C B .
  • the hydroaminated product may include a heterocyclic ring that includes the nitrogen from the amino group and at least one of C A and C B .
  • the nitrogen from the amino group when present in the hydroaminated product, is bonded to a sp 3 carbon atom, and optionally to a hydrogen atom.
  • each of C A and C B in the hydroaminated product is bonded to a sp 3 carbon atom, and optionally to a hydrogen atom.
  • the composition including rhodium and an organic ligand may be formed by combining a rhodium complex and the ligand.
  • the rhodium complex includes a central rhodium atom, one or more ancillary ligands, and optionally one or more counterions.
  • the rhodium complex includes the central rhodium atom, two or more ancillary ligands and a counterion.
  • ancillary ligands include cyclooctadiene, cyclooctene, acetonitrile, acetone, and a halide group.
  • Preferred ancillary ligands include cyclooctadiene, cyclooctene and acetonitrile.
  • Examples of counterions include Cl ⁇ , Br ⁇ , AcO ⁇ , TfO ⁇ , CF 3 CO 2 ⁇ , BF 4 ⁇ , ClO 4 ⁇ , ReO 4 ⁇ , AsF 6 ⁇ , and SbF 6 ⁇ .
  • a preferred counterion is BF 4 ⁇ .
  • the organic ligand includes one or more binding groups, which can bind to the rhodium.
  • binding groups include diphenylphosphino groups (—PPh 2 ), di(cyclohexyl)phosphino groups (—PCy 2 ), di(amido)phosphinato groups (—P(NR 2 ) 2 , where R is an organic group), oxo groups (—O—), and tertiary amino groups (—NR 2 , where R is an organic group).
  • the organic ligand may be monodentate or polydentate, including bidentate, tridentate or tetradentate.
  • organic ligands include triphenylphosphine (PPh 3 ), tricyclohexylphosphine (PCy 3 ), 1,4-bis(diphenylphosphino)butane (DPPB), bis(2-diphenylphosphinophenyl)ether (DPEphos), 1,1′-bis(diphenylphosphino)-ferrocene (DPPF), 9,9-dimethyl-4,5-bis(di-t-butylphosphino)xanthene (t-BuXantphos), 4,5-(bis[bis-diethylamido]phosphonito)-9,9-dimethylxanthene (L1), 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl (L2), and substituted derivatives of these.
  • the ligand is DPPF, t-BuXantphos, L1, L2, or a substituted derivatives of these
  • the ligand t-BuXantphos may be represented by the following structural formula.
  • Ligand L1 is an amino analog of the Xantphos ligand.
  • Ligand L1 may be represented by the following structural formula.
  • Ligand L2 may be represented by the following structural formula.
  • Ligand L2 has been used conventionally for Suzuki cross-coupling (U.S. Pat. Nos. 6,395,916 and 6,307,087). It is commercially available from STREM CHEMICALS, INC. (Newburyport, Mass.).
  • the relative amounts of rhodium and the organic ligand may be varied.
  • the organic ligand may be present in a stoichiometric excess relative to the rhodium.
  • the mole ratio of organic ligand to rhodium is from 0.8 to 2. More preferably the mole ratio of organic ligand to rhodium is from 0.9 to 1.5. More preferably the mole ratio of organic ligand to rhodium is from 1 to 1.2.
  • the reaction mixture may include a solvent.
  • the solvent may be an aprotic solvent, a protic solvent, or a mixture of these.
  • aprotic solvents include hydrocarbons, such as cyclohexane; aromatic hydrocarbons, such as toluene and xylene; halogenated hydrocarbons, such as dichloromethane; halogenated aromatic hydrocarbons, such as dichlorobenzene; ethers, such as tetrahydrofuran and dioxane; ketones, such as acetone and methyl ethyl ketone; and nitriles, such as acetonitrile.
  • protic solvents include water and also include alcohols, such as ethanol, isopropanol, cyclohexanol, and glycols and other polyols.
  • the solvent has a boiling temperature of at least 70° C.
  • the amount of solvent in the reaction mixture may vary. Preferably, if a solvent is present, there is sufficient solvent to solubilize or disperse the substrate, the amino group, and the composition including rhodium and an organic ligand. In one example, the amount of solvent is from 1 to 100 grams per gram of substrate. It may be desirable to use more or less solvent, or to perform the reaction without solvent.
  • the reacting may include forming the reaction mixture.
  • the reaction mixture includes the substrate, the amino group, and the composition including rhodium and an organic ligand, and may include a solvent and/or other ingredients.
  • the reacting includes combining ingredients to form the reaction mixture, where the ingredients include the substrate, the amino group, and the composition including rhodium and an organic ligand.
  • the reacting includes combining ingredients to form the reaction mixture, where the ingredients include the substrate, the amino group, a rhodium complex, and an organic ligand.
  • the amino group optionally may be a substituent group of the substrate, and the ingredients optionally may include a solvent.
  • the reacting may include maintaining the reaction mixture at a temperature of from 25 to 120° C.
  • the reaction temperature is from 30 to 100° C. More preferably the reaction temperature is from 35 to 90° C., and more preferably is from 40 to 80° C.
  • the reaction time may be from 1 to 20 hours. Preferably the reaction time is from 2 to 18 hours. More preferably the reaction time is from 3 to 15 hours, more preferably from 5 to 12 hours, and more preferably from 6 to 10 hours.
  • the hydroaminated product may be recovered from the reaction mixture by typical methods. Examples of recovery methods include extraction, filtration, distillation, crystallization, sublimation, and chromatography.
  • the yield of hydroaminated product is at least 15%.
  • the hydroaminated product is the major product. More preferably the yield of hydroaminated product is at least 25%, more preferably at least 50%, more preferably at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, and more preferably at least 90%.
  • a mixture of an aminoalkene (0.50 mmol), a rhodium complex (0.012 mmol), and a bidentate organic ligand (0.015 mmol) in 0.50 mL of dioxane is allowed to stir at 70° C. for 7 hours.
  • the resulting reaction mixture may be washed with brine and extracted with a solvent such as CH 2 Cl 2 .
  • the combined organic fractions may be dried and concentrated under reduced pressure. The residue may then be purified by chromatography to afford the hydroaminated product.
  • a reaction mixture including an aminoalkene (0.50 mmol), a rhodium complex (0.005 mmol), and a bidentate organic ligand (0.006 mmol) in 0.50 mL of dioxane is allowed to stir at 70° C. for 7 hours.
  • the reaction mixture may then be washed with brine and extracted with a solvent such as CH 2 Cl 2 .
  • the combined organic fractions may be dried and concentrated under reduced pressure. The residue may then be purified by chromatography to afford the hydroaminated product.
  • a reaction mixture of an aminoalkene (0.50 mmol), a rhodium complex (0.025 mmol), and a bidentate organic ligand (0.030 mmol) in 0.50 mL of dioxane is allowed to stir at 100° C. for 10 hours.
  • the reaction mixture may then be washed with brine and extracted with a solvent such as CH 2 Cl 2 .
  • the combined organic fractions may be dried and concentrated under reduced pressure. The residue may then be purified by chromatography to afford the hydroaminated product.
  • FIG. 1 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate 2,2-diphenylpent-4-en-1-amine (1).
  • Cyclized pyrrolidine product A was the hydroaminated product.
  • the ligands used were DPEphos, DPPB, PPh 3 , PCy 3 , DPPF, t-BuXantphos, L1 and L2.
  • the structure of DPEphos is represented below.
  • Table 1 lists the reaction yields for different combinations of rhodium complex and organic ligand. Unless otherwise specified, the reaction mixtures were formed with 0.5 mmol of aminoalkene 1, 2.5 mole percent (mol %) of the rhodium complex, and 0.5 mL of dioxane. For entries 1, 2 and 5-11 and 13, the reaction mixtures were formed with 2.5 mol % of the indicated bidentate organic ligand. For entries 3 and 4, the reaction mixtures were formed with 5 mol % of the indicated monodentate organic ligand. The mole percent values were relative to the amount of aminoalkene 1. The reaction mixtures were heated at 70° C. for 7 hours. The yields listed in Table 1 were gas chromatography (GC) yields.
  • GC gas chromatography
  • compositions in this hydroamination were generated from [Rh(COD) 2 ]BF 4 and either an amino analog of Xantphos (L1), or a biarylphosphine ligand (L2). Compositions containing these ligands formed the hydroaminated product A as the sole detectable product in 86% and 94% yield by GC (Table 1, entries 7 and 12).
  • the composition generated from L2 and [Rh(MeCN) 2 (COD)]BF 4 was similarly active, while the compositions generated from this ligand and either [Rh(COE) 2 Cl] 2 or [Rh(COD)Cl] 2 were less active (Table 1, entries 10 and 11).
  • FIG. 2 represents a reaction scheme for a generic example of the hydroamination of FIG. 1 .
  • R 5 , R 6 and R 7 independently are hydrogen or an organic group.
  • the amino group in the aminoalkene substrate may be a primary amino group or a secondary amino group.
  • the alkenamine substrate may be unsubstituted, or it may be substituted with an alkyl group, a heteroalkyl group, or an aromatic group.
  • R 5 may be hydrogen, an alkyl group or a benzyl group
  • R 6 and R 7 independently may be hydrogen, an alkyl group or a phenyl group
  • n may be 1 or 2.
  • Table 2 represents chemical structures of substrates, their corresponding hydroaminated products, and reaction yields for a variety of hydroamination reactions in which the amino group is a secondary amino group. Unless otherwise specified, the reaction mixtures were formed with 0.5 mmol of the aminoalkene, 2.5 mol % of rhodium complex [Rh(COD) 2 ]BF 4 , 3 mol % of L2 and 0.5 mL of dioxane, and the reaction mixtures were heated at 70° C. for 7 hours. Experimental details are provided in Example 3. The yields listed in Table 2 are isolated yields, for an average of two reactions.
  • FIG. 3 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate N- ⁇ 4-[(2,2-diphenylpent-4-enylamino)methyl]benzyl ⁇ -2,2-diphenylpent-4-en-1-amine, using rhodium complex [Rh(COD) 2 ]BF 4 and ligand L2.
  • Rh(COD) 2 rhodium complex
  • Table 3 represents chemical structures of substrates, their corresponding hydroaminated products, and reaction yields for a variety of hydroamination reactions in which the amino group is a primary amino group. Unless otherwise specified, the reaction mixtures were formed with 0.5 mmol of the aminoalkene, 5 mol % of rhodium complex [Rh(COD) 2 ]BF 4 , 6 mol % of L2 and 0.5 mL of dioxane, and the reaction mixtures were heated at 100° C. for 10 hours. Experimental details are provided in Example 4. The yields listed in Table 3 are isolated yields, except where noted.
  • TLC thin-layer chromatography
  • THF and diethyl ether were obtained as HPLC grade without inhibitors. Benzene, toluene, dichloromethane, and acetonitrile were obtained as ACS reagent grade. THF, diethyl ether, benzene, toluene, and dichloromethane were degassed by purging with nitrogen for 45 min and dried with a solvent purification system containing a 1 meter column containing activated alumina. Anhydrous 1,4-dioxane was obtained from ALDRICH (St. Louis, Mo.) and used without further purification. 1,4-Dioxane-d 8 was dried over appropriate drying agents and vacuum transferred prior to use. The rhodium complexes and 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl (L2) were used as received from STREM.
  • N-methyl-2,2-diphenylpent-4-en-1-amine was prepared according to Stubbert, B. D. et al. J. Am. Chem. Soc. 129, 4253, 2007.
  • N-(Cyclohexylmethyl)-2,2-diphenylpent-4-en-1-amine was prepared from 2,2-diphenylpent-4-enylamine and cyclohexanecarboxaldehyde according to the procedure used for preparation of N-benzyl-2,2-diphenylpent-4-en-1-amine.
  • the product was obtained in a 97% yield as a colorless oil.
  • N-(4-methoxybenzyl)-2,2-diphenylpent-4-en-1-amine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 94% yield as a colorless oil.
  • Methyl 4-[(2,2-diphenylpent-4-enylamino)methyl]benzoate was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 92% yield as a colorless oil.
  • N-Benzyl-2,2-dimethylpent-4-en-1-amine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 96% yield as a colorless oil.
  • N-Benzylpent-4-en-1-amine was prepared according to Gribkov, D. V. et al. Angew. Chem. Int. Ed. Engl. 43, 5542, 2004. The compound was obtained in 85% yield as a colorless oil.
  • N- ⁇ 4-[(2,2-diphenylpent-4-enylamino)methyl]benzyl- ⁇ -2,2-diphenylpent-4-en-1-amine was obtained from 2,2-diphenylpent-4-enylamine and terephthaldicarboxaldehyde according to the procedure used for the preparation of N-benzyl-2,2-diphenylpent-4-en-1-amine.
  • the compound was obtained in a 91% yield as a colorless oil.
  • 1 H NMR (500 MHz, CDCl 3 ) ⁇ 1.74 (s, 6H), 2.44 (s, 3H), 2.71 (s, 2H), 3.60 (s, 2H), 7.27 (t, J 7.5 Hz, 2H), 7.36-7.45 (m, 8H); 13 C NMR (125 MHz, CDCl 3 ) ⁇ 24.6, 34.6, 52.1, 54.7, 60.6, 67.6, 125.9, 127.5, 128.4, 150.4.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A method includes reacting an amino group, a composition including rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture.
Figure US20120190854A1-20120726-C00001
R1 is an organic group including a sp3 carbon atom bonded to CA. R2 is selected from the group consisting of hydrogen, methyl, and an organic group including a sp3 carbon atom bonded to CA. R3 and R4 independently are selected from the group consisting of hydrogen, methyl, and an organic group including a sp3 carbon atom bonded to CB. The method further includes forming a hydroaminated product in the reaction mixture.

Description

    CROSS-REFERENCE To RELATED APPLICATIONS
  • This application is a divisional application of U.S. patent application Ser. No. 12/251,062 entitled “Hydroamination of Alkenes” filed Oct. 14, 2008, which claims the benefit of U.S. Provisional Application No. 60/979,652 entitled “Catalytic Hydroamination of Alkenes” filed Oct. 12, 2007, each of which is incorporated by reference in its entirety.
  • FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • This invention was made with government support under contract number(s) GM 55382 awarded by the National Institutes of Health, under Grant Number. The government has certain rights in the invention.
  • BACKGROUND
  • Alkylamines are among the most common functional groups in pharmaceuticals. The hydroamination of alkenes is one of the simplest and most atom-economical methods to prepare alkylamines, and much effort has now been spent to develop catalysts for such additions of amines to alkenes.
  • One of the earliest reports of hydroamination was the hydroamination of ethylene with secondary amines, catalyzed by rhodium trichloride (Coulson, D. R. Tetrahedron Lett. 12, 429, 1971). A drawback to this approach is that the reaction has only been demonstrated with unsubstituted ethylene, and only when reacted at high temperatures. Most research has been focused on hydroamination of substituted alkenes at temperatures below 100° C.
  • One approach to hydroamination has been to use activated alkenes. Examples of activated alkenes include alkenes in strained ring systems, such as norbornenes, which have been subjected to hydroamination catalyzed by complexes of transition metals such as iridium (A. L. Casalnuovo et al. J. Am. Chem. Soc. 110, 6738, 1988; R. Dorta et al. J. Am. Chem. Soc. 119, 10857, 1997). Examples of activated alkenes also include vinyl arenes, which have been subjected to hydroamination catalyzed by complexes of transition metals such as rhodium (Beller, M. et al. Eur. J. Inorg. Chem. 1121, 1999; Beller, M. et al. Chem. Eur. J. 5, 1306, 1999). Examples of activated alkenes also include allenes, which have been subjected to hydroamination catalyzed by complexes of transition metals such as titanium (Walsh, P. J. et al. J. Am. Chem. Soc. 114, 1708, 1992; Johnson, J. S. et al. J. Am. Chem. Soc. 123, 2923, 2001.). These reactions have met with mixed success.
  • Activated alkenes such as vinyl arenes, 1,3-dienes, acrylates and acrylonitriles have been subjected to hydroamination catalyzed by complexes of transition metals such as iron, cobalt, nickel, ruthenium, rhodium, palladium, osmium, iridium, and platinum (Kawatsura, M. et al. J. Am. Chem. Soc. 122, 9546, 2000; O. Löber et al. J. Am. Chem. Soc. 123, 4366, 2001; Utsunomiya, M. et al. J. Am. Chem. Soc. 125, 5608, 2003; Utsunomiya, M. et al. J. Am. Chem. Soc. 126, 2702, 2004; Takemiya, A. et al. J. Am. Chem. Soc. 128, 6042, 2006). In many cases, these reactions could be performed at room temperature with high yields. Enantioselectivity also could be observed for some systems. A drawback to this approach is that the reactants have included either a vinyl arene or an aromatic amine. Thus, simple alkylamine products have not been reported. Also, hydroamination has been reported only for activated alkenes, in which one carbon of the carbon-carbon double bond was bonded to a sp2 hybridized carbon, such as a ring carbon of an aromatic ring, a carbon of another carbon-carbon double bond, a carbonyl carbon (>C═O), or a carbon of a cyano group. The need for an activated alkene limits the scope of substrates that can be used.
  • Another approach to hydroamination has been to use activated nitrogen sources, instead of amines. Activated nitrogen sources such as sulfonamides, amides and carbamates have been added to vinylarenes, allenes and alkenes. These reactions have been catalyzed by late transition metals, such as iron, palladium, platinum, copper and gold, as well as by protic acids. A drawback to these reactions is that the products do not include simple amino groups, and thus are not alkylamines.
  • Yet another approach to hydroamination has employed catalytic complexes of lanthanides, actinides, or group IV transition metals such as titanium or zirconium. These catalysts can be highly efficient, and can be used for hydroamination of unactivated alkenes. However, a drawback to this approach is that the catalysts are highly sensitive to air and moisture, and do not have good tolerance of functional groups. Thus, these reactions have not been used widely in the synthesis of complex organic molecules.
  • It would be desirable to transform unactivated alkenes into alkylamines in a way that is relatively insensitive to air and moisture. It would also be desirable to provide alkylamines from substrates that include one or more functional groups in addition to the alkene group. Ideally, such a system would provide alkylamines from terminal or internal alkenes, using primary or secondary amino groups.
  • SUMMARY
  • In one aspect, the invention provides a method including reacting an amino group, a composition including rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture.
  • Figure US20120190854A1-20120726-C00002
  • R1 is an organic group including a sp3 carbon atom bonded to CA. R2 is selected from the group consisting of hydrogen, methyl, and an organic group including a sp3 carbon atom bonded to CA. R3 and R4 independently are selected from the group consisting of hydrogen, methyl, and an organic group including a sp3 carbon atom bonded to CB. The method further includes forming a hydroaminated product in the reaction mixture.
  • In another aspect, the invention provides a composition including rhodium, and an organic ligand selected from the group consisting of 4,5-(bis[bis-diethylamido]-phosphonito)-9,9-dimethylxanthene, 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl, and substituted derivatives of these.
  • In yet another aspect, the invention provides a catalyst including rhodium and an organic ligand. When 0.5 millimole (mmol) of 2,2-diphenylpent-4-en-1-amine is combined with the catalyst in 0.5 milliliter (mL) of dioxane to form a reaction mixture, such that the catalyst is present in the reaction mixture in an amount providing 2.5 mole percent (mol %) rhodium relative to the amine, and the reaction mixture is heated at 70° C. for 7 hours, the yield of 1,2-dimethyl-4,4-diphenyl-pyrrolidine is at least 65%.
  • The following definitions are included to provide a clear and consistent understanding of the specification and claims.
  • The term “group” means a linked collection of atoms or a single atom within a molecular entity, where a molecular entity is any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity. The description of a group as being “formed by” a particular chemical transformation does not imply that this chemical transformation is involved in making the molecular entity that includes the group.
  • The term “organic group” means a group containing at least one carbon atom.
  • The term “amino group” means a group formed by removing a hydrogen from ammonia (NH3), from the nitrogen of a primary amine compound (RNH2) or from the nitrogen of a secondary amine compound (R′R″NH), where R, R′ and R″ are organic groups. A primary amino group may be represented by the structural formula —NH2, and a secondary amino group may be represented by the structural formula —NRH.
  • The term “alkene” means an acyclic or cyclic compound consisting entirely of hydrogen atoms and carbon atoms, and including at least one carbon-carbon double bond. An alkene may be substituted with one or more substituent groups, which may include atoms other than carbon and hydrogen.
  • The term “substituent group” means a group that replaces one or more hydrogen atoms in a molecular entity. Examples of substituent groups include halide groups, alkyl groups, heteroalkyl groups, aryl groups, and heteroaryl groups.
  • The term “substituted derivative” means a compound in which one or more hydrogen atoms has been replaced with a substituent group.
  • The term “complex” means a molecular entity including a central metal atom, to which is associated a surrounding array of other groups of atoms, referred to as “ligands.”
  • The term “ligand”, when referring to a distinct substance, means an organic compound that can be associated to a metal atom when combined with the metal atom.
  • The term “sp3 carbon atom” means a carbon atom that is bonded to four other atoms through individual single bonds.
  • The term “heterocyclic group” means a group formed by removing a hydrogen from a ring atom of a heterocyclic compound, where a heterocyclic compound is a cyclic compound having as ring members carbon and at least one other element. Heterocyclic groups include heterocycloalkyl groups, heteroaryl groups, and mixtures of these. A heterocyclic group may be monocyclic or polycyclic and may be substituted with one or more substituent groups.
  • The term “functional group” means a group that includes atoms other than hydrogen and sp3 carbon atoms, and that has similar chemical properties when it occurs in different organic compounds. Examples of functional groups include hydroxyl (—OH), protected hydroxyl, ether (—C—O—C—), ketone (>C═O), ester (—C(═O)O—C‘), carboxylic acid (—C(═O)OH), cyano (—C≡N), amido (—C(═O)NH—C—), protected amino, thiol (—SH), sulfone, sulfoxide, phosphine, phosphite, phosphate, and halide (—X).
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention can be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
  • FIG. 1 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate 2,2-diphenylpent-4-en-1-amine (1).
  • FIG. 2 represents a reaction scheme for a generic example of the hydroamination of FIG. 1.
  • FIG. 3 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate N-{4-[(2,2-diphenylpent-4-enylamino)methyl]benzyl}-2,2-diphenylpent-4-en-1-amine.
  • DETAILED DESCRIPTION
  • The present invention makes use of the discovery that amines can be added to unactivated alkenes using a composition that includes a rhodium complex. These hydroaminations are mild and can proceed with high yields. Both primary and secondary amines may be added to the alkene. A wide variety of alkene substrates may be used, including 1,1- and 1,2-disubstituted alkenes and alkenes that include other functional groups.
  • A method may include reacting an amino group, a composition including rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture.
  • Figure US20120190854A1-20120726-C00003
  • R1 is an organic group including a sp3 carbon atom bonded to CA. R2 is hydrogen, methyl, or an organic group including a sp3 carbon atom bonded to CA. R3 and R4 independently are hydrogen, methyl, or an organic group including a sp3 carbon atom bonded to CB. The reaction mixture may include a solvent, and may include other ingredients. The method further includes forming a hydroaminated product in the reaction mixture.
  • The substrate includes a carbon-carbon double bond, represented in formula (I) as CA═CB. In addition to the double bond with CB, carbon CA is bonded either to two sp3 carbon atoms, or to hydrogen and a sp3 carbon atom. In addition to the double bond with CA, carbon CB is bonded to two hydrogens, to two sp3 carbon atoms, or to hydrogen and a sp3 carbon atom. For example, referring to structural formula (I), each of R2, R3 and R4 may be hydrogen, such that the double bond is mono-substituted. In another example, R2 is methyl or an organic group including a sp3 carbon atom bonded to CA, and R3 and R4 are hydrogen, such that the double bond is 1,1 di-substituted. In another example, R2 is hydrogen, and one of R3 and R4 is methyl or an organic group including a sp3 carbon atom bonded to CB, such that the double bond is 1,2 di-substituted.
  • An advantage of this method is that the substrate may include at least one functional group. In conventional hydroamination reactions, functional groups in the substrate can hinder or prevent the desired addition of the amino group. Preferably the substrate may include at least one functional group such as hydroxyl (—OH), protected hydroxyl, ether (—O—C—), ketone (>C═O), ester (—C(═O)O—C—), carboxylic acid (—C(═O)OH), cyano (—C≡N), amido (—C(═O)NH—C—), protected amino, thiol (—SH), sulfone, sulfoxide, phosphine, phosphite, phosphate, halide (—X), and combinations of these.
  • The amino group may be a primary amino group (—NH2) or a secondary amino group (—NRH, where R is an organic group). The compound for which the amino group is a substituent may be, for example, an alkane, a heteroalkane, an alkene, a heteroalkene, or an aromatic compound. The compound may include one or more other substituent groups. Preferably the amino group is a substituent of an alkane or a heteroalkane.
  • The amino group may be present as part of a compound separate from the substrate, or it may be present as part of the substrate. If the amino group is a substituent group of another compound, separate from the substrate, then a hydroamination reaction between the amino group and the carbon-carbon double bond is an intermolecular reaction. In contrast, if the amino group is a substituent group of the substrate, then a hydroamination reaction between the amino group and the carbon-carbon double bond is an intramolecular reaction.
  • The hydroaminated product includes a carbon-carbon single bond (CA-CB) in place of the carbon-carbon double bond (CA═CB), and includes an amino group bonded to one of CA and CB. For intramolecular reactions, the hydroaminated product may include a heterocyclic ring that includes the nitrogen from the amino group and at least one of CA and CB. Preferably the nitrogen from the amino group, when present in the hydroaminated product, is bonded to a sp3 carbon atom, and optionally to a hydrogen atom. Preferably each of CA and CB in the hydroaminated product is bonded to a sp3 carbon atom, and optionally to a hydrogen atom.
  • The composition including rhodium and an organic ligand may be formed by combining a rhodium complex and the ligand. In this example, the rhodium complex includes a central rhodium atom, one or more ancillary ligands, and optionally one or more counterions. Preferably the rhodium complex includes the central rhodium atom, two or more ancillary ligands and a counterion. Examples of ancillary ligands include cyclooctadiene, cyclooctene, acetonitrile, acetone, and a halide group. Preferred ancillary ligands include cyclooctadiene, cyclooctene and acetonitrile. Examples of counterions include Cl, Br, AcO, TfO, CF3CO2 , BF4 , ClO4 , ReO4 , AsF6 , and SbF6 . A preferred counterion is BF4 .
  • The organic ligand includes one or more binding groups, which can bind to the rhodium. Examples of binding groups include diphenylphosphino groups (—PPh2), di(cyclohexyl)phosphino groups (—PCy2), di(amido)phosphinato groups (—P(NR2)2, where R is an organic group), oxo groups (—O—), and tertiary amino groups (—NR2, where R is an organic group). The organic ligand may be monodentate or polydentate, including bidentate, tridentate or tetradentate.
  • Specific examples of organic ligands include triphenylphosphine (PPh3), tricyclohexylphosphine (PCy3), 1,4-bis(diphenylphosphino)butane (DPPB), bis(2-diphenylphosphinophenyl)ether (DPEphos), 1,1′-bis(diphenylphosphino)-ferrocene (DPPF), 9,9-dimethyl-4,5-bis(di-t-butylphosphino)xanthene (t-BuXantphos), 4,5-(bis[bis-diethylamido]phosphonito)-9,9-dimethylxanthene (L1), 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl (L2), and substituted derivatives of these. Preferably the ligand is DPPF, t-BuXantphos, L1, L2, or a substituted derivative thereof. More preferably the ligand is L1, L2, or a substituted derivative thereof.
  • The ligand t-BuXantphos may be represented by the following structural formula.
  • Figure US20120190854A1-20120726-C00004
  • Ligand L1 is an amino analog of the Xantphos ligand. Ligand L1 may be represented by the following structural formula.
  • Figure US20120190854A1-20120726-C00005
  • Ligand L2 may be represented by the following structural formula.
  • Figure US20120190854A1-20120726-C00006
  • Ligand L2 has been used conventionally for Suzuki cross-coupling (U.S. Pat. Nos. 6,395,916 and 6,307,087). It is commercially available from STREM CHEMICALS, INC. (Newburyport, Mass.).
  • The relative amounts of rhodium and the organic ligand may be varied. The organic ligand may be present in a stoichiometric excess relative to the rhodium. Preferably the mole ratio of organic ligand to rhodium is from 0.8 to 2. More preferably the mole ratio of organic ligand to rhodium is from 0.9 to 1.5. More preferably the mole ratio of organic ligand to rhodium is from 1 to 1.2.
  • The reaction mixture may include a solvent. The solvent may be an aprotic solvent, a protic solvent, or a mixture of these. Examples of aprotic solvents include hydrocarbons, such as cyclohexane; aromatic hydrocarbons, such as toluene and xylene; halogenated hydrocarbons, such as dichloromethane; halogenated aromatic hydrocarbons, such as dichlorobenzene; ethers, such as tetrahydrofuran and dioxane; ketones, such as acetone and methyl ethyl ketone; and nitriles, such as acetonitrile. Examples of protic solvents include water and also include alcohols, such as ethanol, isopropanol, cyclohexanol, and glycols and other polyols. Preferably the solvent has a boiling temperature of at least 70° C.
  • The amount of solvent in the reaction mixture may vary. Preferably, if a solvent is present, there is sufficient solvent to solubilize or disperse the substrate, the amino group, and the composition including rhodium and an organic ligand. In one example, the amount of solvent is from 1 to 100 grams per gram of substrate. It may be desirable to use more or less solvent, or to perform the reaction without solvent.
  • The reacting may include forming the reaction mixture. The reaction mixture includes the substrate, the amino group, and the composition including rhodium and an organic ligand, and may include a solvent and/or other ingredients. In one example, the reacting includes combining ingredients to form the reaction mixture, where the ingredients include the substrate, the amino group, and the composition including rhodium and an organic ligand. In another example, the reacting includes combining ingredients to form the reaction mixture, where the ingredients include the substrate, the amino group, a rhodium complex, and an organic ligand. In each example, the amino group optionally may be a substituent group of the substrate, and the ingredients optionally may include a solvent.
  • The reacting may include maintaining the reaction mixture at a temperature of from 25 to 120° C. Preferably the reaction temperature is from 30 to 100° C. More preferably the reaction temperature is from 35 to 90° C., and more preferably is from 40 to 80° C.
  • The reaction time may be from 1 to 20 hours. Preferably the reaction time is from 2 to 18 hours. More preferably the reaction time is from 3 to 15 hours, more preferably from 5 to 12 hours, and more preferably from 6 to 10 hours.
  • The hydroaminated product may be recovered from the reaction mixture by typical methods. Examples of recovery methods include extraction, filtration, distillation, crystallization, sublimation, and chromatography. Preferably the yield of hydroaminated product is at least 15%. Preferably the hydroaminated product is the major product. More preferably the yield of hydroaminated product is at least 25%, more preferably at least 50%, more preferably at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, and more preferably at least 90%.
  • In an example of the method, a mixture of an aminoalkene (0.50 mmol), a rhodium complex (0.012 mmol), and a bidentate organic ligand (0.015 mmol) in 0.50 mL of dioxane is allowed to stir at 70° C. for 7 hours. The resulting reaction mixture may be washed with brine and extracted with a solvent such as CH2Cl2. The combined organic fractions may be dried and concentrated under reduced pressure. The residue may then be purified by chromatography to afford the hydroaminated product.
  • In another example of the method, a reaction mixture including an aminoalkene (0.50 mmol), a rhodium complex (0.005 mmol), and a bidentate organic ligand (0.006 mmol) in 0.50 mL of dioxane is allowed to stir at 70° C. for 7 hours. The reaction mixture may then be washed with brine and extracted with a solvent such as CH2Cl2. The combined organic fractions may be dried and concentrated under reduced pressure. The residue may then be purified by chromatography to afford the hydroaminated product.
  • In another example of the method, a reaction mixture of an aminoalkene (0.50 mmol), a rhodium complex (0.025 mmol), and a bidentate organic ligand (0.030 mmol) in 0.50 mL of dioxane is allowed to stir at 100° C. for 10 hours. The reaction mixture may then be washed with brine and extracted with a solvent such as CH2Cl2. The combined organic fractions may be dried and concentrated under reduced pressure. The residue may then be purified by chromatography to afford the hydroaminated product.
  • FIG. 1 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate 2,2-diphenylpent-4-en-1-amine (1). Cyclized pyrrolidine product A was the hydroaminated product. The ligands used were DPEphos, DPPB, PPh3, PCy3, DPPF, t-BuXantphos, L1 and L2. The structure of DPEphos is represented below.
  • Figure US20120190854A1-20120726-C00007
  • Table 1 lists the reaction yields for different combinations of rhodium complex and organic ligand. Unless otherwise specified, the reaction mixtures were formed with 0.5 mmol of aminoalkene 1, 2.5 mole percent (mol %) of the rhodium complex, and 0.5 mL of dioxane. For entries 1, 2 and 5-11 and 13, the reaction mixtures were formed with 2.5 mol % of the indicated bidentate organic ligand. For entries 3 and 4, the reaction mixtures were formed with 5 mol % of the indicated monodentate organic ligand. The mole percent values were relative to the amount of aminoalkene 1. The reaction mixtures were heated at 70° C. for 7 hours. The yields listed in Table 1 were gas chromatography (GC) yields.
  • TABLE 1
    Effect of Ligand on the Selectivity for Intramolecular Hydroamination
    of 2,2-Diphenylpent-4-en-1-amine (1)
    Yields of Products
    Organic Listed in FIG. 1
    Entry Rhodium Complex Ligand % A % B % C % D
     1 [Rh(COD)2]BF4 DPEphos 0 0 93 0
     2 [Rh(COD)2]BF4 DPPB 10 40 10 30
     3 [Rh(COD)2]BF4 PPh3 0 0 92 0
     4 [Rh(COD)2]BF4 PCy3 0 30 30 30
     5 [Rh(COD)2]BF4 DPPF 20 30 10 30
     6 [Rh(COD)2]BF4 t-BuXantphos 60 10 10 10
     7 [Rh(COD)2]BF4 L1 86 0 0 0
     8 [Rh(COD)2]BF4 L2 93 0 0 0
     9 [Rh(MeCN)2(COD)]BF4 L2 92 0 0 0
    10a [Rh(COE)2Cl]2 L2 28 0 0 0
    11a [Rh(COD)Cl]2 L2 9 0 0 0
    12b [Rh(COD)2]BF4 L2 94 0 0 0
    13 5% HBF4 L2 0 0 0 0
    a1.25% rhodium was employed with low conversion.
    b1% of rhodium complex and 1.2% ligand were used.
  • Reaction of aminoalkene 1 in the presence of 2.5 mol % [Rh(COD)2]BF4 and 2.5 mol % DPEphos (Table 1, entry 1) formed none of the hydroaminated product (1,2-dimethyl-4,4-diphenylpyrrolidine) (A in FIG. 1). Conventionally, this combination of rhodium complex and organic ligand has been used for the anti-Markovnikov hydroamination of vinylarenes (Utsunomiya, M. et al., J. Am. Chem. Soc. 2003, 125, 5608). Instead, the major new species from this reaction resulted from isomerization of the alkene from the terminal to the internal position. Reactions performed in the presence of 2.5 mol % [Rh(COD)2]BF4 and 2.5 mol % DPPB (Table 1, entry 2) also led to little hydroaminated product A. Conventionally, this combination of rhodium complex and organic ligand has been used for the intramolecular hydroamination of vinylarenes (Takemiya, A. et al., J. Am. Chem. Soc. 2006, 128, 6042). Instead, a combination of amine, isomerized alkene, cyclic enamine and the hydroaminated alkylamine A were formed. The hydroaminated product accounted for only 10% of the total reaction product.
  • Studies with other ligands indicated a strong dependence of the selectivity of the process on the identity of the phosphine. Reactions conducted with PPh3 as ligand gave only isomerized product (Table 1, entry 3). Those conducted with DPPF generated roughly 20% hydroaminated product A (Table 1, entry 5), while those conducted with t-BuXantphos generated roughly 60% of the hydroaminated product A (Table 1, entry 6).
  • The most selective compositions in this hydroamination were generated from [Rh(COD)2]BF4 and either an amino analog of Xantphos (L1), or a biarylphosphine ligand (L2). Compositions containing these ligands formed the hydroaminated product A as the sole detectable product in 86% and 94% yield by GC (Table 1, entries 7 and 12). The composition generated from L2 and [Rh(MeCN)2(COD)]BF4 was similarly active, while the compositions generated from this ligand and either [Rh(COE)2Cl]2 or [Rh(COD)Cl]2 were less active (Table 1, entries 10 and 11). Reactions in dioxane occurred faster and in higher yield than those in MeCN, THF and toluene. The yield of hydroaminated product A was similar when 1 mol % [Rh(COD)2]BF4 and 1.2 mol % ligand L2 were employed (Table 1, entry 11) as when 2.5 mol % [Rh(COD)2]BF4 and 5 mol % ligand L2 were used. No reaction was observed at this temperature in the presence of acid alone (Table 1, entry 13). Preferred conditions for hydroamination of this aminoalkene using ligand L2 are shown in entry 12 of Table 1.
  • For the composition formed from [Rh(COD)2]BF4 and L2, a small concentration of active catalyst may be involved in the hydroamination reaction. In hydroamination reactions with this composition, 31P NMR spectroscopy indicated that the addition of L2 to the rhodium complex provided a solution containing predominantly free ligand, and only 8 mol % of a rhodium-phosphine complex, even after 3 hours at 70° C. However, control experiments confirmed that, in this example, the ligand was necessary to observe hydroamination.
  • FIG. 2 represents a reaction scheme for a generic example of the hydroamination of FIG. 1. In FIG. 2, R5, R6 and R7 independently are hydrogen or an organic group. The amino group in the aminoalkene substrate may be a primary amino group or a secondary amino group. The alkenamine substrate may be unsubstituted, or it may be substituted with an alkyl group, a heteroalkyl group, or an aromatic group. In one example, R5 may be hydrogen, an alkyl group or a benzyl group; R6 and R7 independently may be hydrogen, an alkyl group or a phenyl group; and n may be 1 or 2.
  • Table 2 represents chemical structures of substrates, their corresponding hydroaminated products, and reaction yields for a variety of hydroamination reactions in which the amino group is a secondary amino group. Unless otherwise specified, the reaction mixtures were formed with 0.5 mmol of the aminoalkene, 2.5 mol % of rhodium complex [Rh(COD)2]BF4, 3 mol % of L2 and 0.5 mL of dioxane, and the reaction mixtures were heated at 70° C. for 7 hours. Experimental details are provided in Example 3. The yields listed in Table 2 are isolated yields, for an average of two reactions.
  • The reactions listed in Table 2 helped to illustrate the scope of the hydroamination of 5- and 6-N-alkyl aminoalkenes to form nitrogen heterocycles. A variety of 5-aminoalkenes underwent hydroamination to generate the corresponding hydroaminated product in excellent yields (Table 2, entries 1-10). Generation of high yields of hydroaminated products was observed not only for N-methyl aminoalkenes, but also more bulky secondary amines, such as N-cyclohexylmethyl and N-benzyl amines (Table 2, entries 1-3).
  • Surprisingly, many functional groups, such as halides, ethers, nitriles, and esters, were tolerated (Table 2, entries 4-7). Perhaps most remarkable, reaction of the substrate in entry 10 of Table 2, which contained an allylic alcohol function, occurred in good yield with high diastereoselectivity, without significant decomposition of the alcohol or deactivation of the rhodium. This was the first demonstration that a free hydroxyl group could be tolerated during alkene hydroamination. In a similarly surprising way, the reaction of N-(4-methoxybenzyl)-2,2-diphenylpent-4-en-1-amine (substrate in Table 2, entry 5) occurred in 90% yield, even when the reaction was conducted with 5.0 equiv of added water.
  • TABLE 2
    Intramolecular Hydroamination of Secondary Aminoalkenes
    Yield
    Entry Aminoalkene Product (%)
     1
    Figure US20120190854A1-20120726-C00008
    Figure US20120190854A1-20120726-C00009
    90 a
     2
    Figure US20120190854A1-20120726-C00010
    Figure US20120190854A1-20120726-C00011
    Figure US20120190854A1-20120726-C00012
    Figure US20120190854A1-20120726-C00013
    91 
     3 Ar = Phenyl 91 
     4 Ar = 4-C6H4Cl 99 
     5 Ar = 4-C6H4OMe 98 
     6 Ar = 4-C6H4CN 85 
     7 Ar = 4-C6H4CO2Me 94 
     8
    Figure US20120190854A1-20120726-C00014
    Figure US20120190854A1-20120726-C00015
    83 
     9
    Figure US20120190854A1-20120726-C00016
    Figure US20120190854A1-20120726-C00017
    92 
    10
    Figure US20120190854A1-20120726-C00018
    Figure US20120190854A1-20120726-C00019
    65 (11:1)
    11
    Figure US20120190854A1-20120726-C00020
    Figure US20120190854A1-20120726-C00021
    64 
    12
    Figure US20120190854A1-20120726-C00022
    Figure US20120190854A1-20120726-C00023
    96 
    13
    Figure US20120190854A1-20120726-C00024
    Figure US20120190854A1-20120726-C00025
    76 b
    14
    Figure US20120190854A1-20120726-C00026
    Figure US20120190854A1-20120726-C00027
    86 b
    a 1 mol % of rhodium complex and 1.2 mol % of L2 were employed.
    b 5 mol % of rhodium complex and 6 mol % of L2 were used, and reaction was run at 100° C.
  • It has been reported that geminal disubstitution facilitates intramolecular hydroamination (Curtin, M. L. et al., J. Org. Chem. 1990, 55, 5278). However, even substrates lacking substituents between the alkene and the amine underwent cyclization in the presence of the composition generated from [Rh(COD)2]BF4 and L2. For example, N-benzyl-5-aminopentene cyclized to form the corresponding pyrrolidine in 64% yield (Table 2, entry 11).
  • Successful reactions of amines with disubstituted alkenes have been limited. Surprisingly, cyclization of the 1,1-disubstituted alkene in entry 12 of Table 2 occurred in excellent yield. Even more challenging is the reaction of amines with internal alkenes. No previous late metal composition has led to the addition of an N—H bond of an amine across an internal alkene. Surprisingly, the reaction of the 1,2-disubstituted aminoalkene in entry 13 of Table 2 occurred in good yield at 100° C.
  • Most of the reactions listed in Table 2 yielded hydroaminated products that included a five-membered ring. However, reaction with the composition also led to cyclizations to form six-membered rings in high yields, as shown by the example in entry 14 of Table 2.
  • In addition to the reactions listed in Table 2, the scope of the hydroamination of 5- and 6-N-alkyl aminoalkenes to form nitrogen heterocycles was illustrated by performing two sequential hydroaminations. FIG. 3 represents chemical structures and a reaction scheme for an example of hydroamination of the aminoalkene substrate N-{4-[(2,2-diphenylpent-4-enylamino)methyl]benzyl}-2,2-diphenylpent-4-en-1-amine, using rhodium complex [Rh(COD)2]BF4 and ligand L2. A doubly hydroaminated product was achieved in excellent yield.
  • Table 3 represents chemical structures of substrates, their corresponding hydroaminated products, and reaction yields for a variety of hydroamination reactions in which the amino group is a primary amino group. Unless otherwise specified, the reaction mixtures were formed with 0.5 mmol of the aminoalkene, 5 mol % of rhodium complex [Rh(COD)2]BF4, 6 mol % of L2 and 0.5 mL of dioxane, and the reaction mixtures were heated at 100° C. for 10 hours. Experimental details are provided in Example 4. The yields listed in Table 3 are isolated yields, except where noted.
  • TABLE 3
    Intramolecular Hydroamination of Primary Aminoalkenes
    Entry Aminoalkene Product Yield (%)
    1
    Figure US20120190854A1-20120726-C00028
    Figure US20120190854A1-20120726-C00029
    83 
    2
    Figure US20120190854A1-20120726-C00030
    Figure US20120190854A1-20120726-C00031
    84 
    3
    Figure US20120190854A1-20120726-C00032
    Figure US20120190854A1-20120726-C00033
    96 a
    4
    Figure US20120190854A1-20120726-C00034
    Figure US20120190854A1-20120726-C00035
    74 b
    a Reaction was performed for 1 day.
    b NMR yield.
  • The reactions listed in Table 3 helped to illustrate further the scope of the hydroamination reaction. The composition generated from 5 mol % [Rh(COD)2]BF4 and 6 mol % of L2 provided for the formation of a hydroamination product from aminoalkenes containing primary amine units. The primary aminoalkenes cyclized to form five- and six-membered rings in good yields. These results are surprising and unexpected, since no late transition metal has ever been reported to catalyze the addition of primary alkylamines across alkenes.
  • The following examples are provided to illustrate one or more preferred embodiments of the invention. Numerous variations may be made to the following examples that lie within the scope of the invention.
  • EXAMPLES
  • General Procedures. All manipulations were conducted under an inert atmosphere using a nitrogen-filled glovebox (INNOVATIVE TECHNOLOGIES, Newburyport, Mass.) equipped with an oxygen sensor (working oxygen level <2.0 ppm) and low-temperature refrigeration unit (−35° C.). All reactions were conducted in flame- or oven-dried round-bottomed flasks fitted with rubber septa under a positive pressure of argon, or in 1-dram vials fitted with a Teflon-lined screw cap (13-mm diameter, 425 GPI thread; QORPAK, Bridgeville, Pa.) under an atmosphere of nitrogen, unless otherwise noted. Organic solutions were concentrated by rotary evaporation at 25-40° C. Analytical thin-layer chromatography (TLC) was performed using glass plates pre-coated with silica gel (0.25 mm, 60 A pore size) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized by exposure to ultraviolet light (UV) and/or submersion in aqueous ceric ammonium molybdate solution (CAM) or aqueous potassium permanganate solution (KMnO4), followed by brief heating on a hot plate (175° C., 10-15 s).
  • Materials. THF and diethyl ether were obtained as HPLC grade without inhibitors. Benzene, toluene, dichloromethane, and acetonitrile were obtained as ACS reagent grade. THF, diethyl ether, benzene, toluene, and dichloromethane were degassed by purging with nitrogen for 45 min and dried with a solvent purification system containing a 1 meter column containing activated alumina. Anhydrous 1,4-dioxane was obtained from ALDRICH (St. Louis, Mo.) and used without further purification. 1,4-Dioxane-d8 was dried over appropriate drying agents and vacuum transferred prior to use. The rhodium complexes and 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl (L2) were used as received from STREM.
  • Instrumentation. 1H NMR spectra were obtained at 400 or 500-MHz and recorded relative to residual protio-solvent. 13C NMR spectra were obtained at 100 or 125 MHz, and chemical shifts were recorded relative to the solvent resonance. 31P NMR spectra were obtained at 122, 162 or 202 MHz, and chemical shifts are reported relative to 85% H3PO4. Analytical gas chromatography (GC) was performed using a HEWLETT-PACKARD 5890 Gas Chromatograph fitted with a flame ionization detector.
  • Example 1 Synthesis of 4,5-(Bis[bis-diethylamido]phosphonito)-9,9-dimethylxanthene (L1)
  • This compound was prepared according to Goertz, W. et al. Chem. Eur. J. 7, 1614, 2001. 1H NMR (500 MHz, CDCl3): δ 1.02 (t, J=7.0 Hz, 24H), 1.60 (s, 6H), 3.05-3.12 (m, 16H), 7.05 (t, J=7.5 Hz, 2H), 7.33-7.36 (m, 4H); 13C NMR (125 Hz, CDCl3): δ 14.6, 33.2, 34.1, 43.3, 122.2, 125.9, 129.5, 130.0, 130.7, 150.7; 31P{1H} NMR (202 MHz, CDCl3): δ 90.9 (s).
  • Example 2 Synthesis of Alkenamines
  • 2,2-Diphenylpent-4-en-1-amine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. 1H NMR (400 MHz, CDCl3) δ 0.87 (s, 2H), 2.95 (d, J=7.2 Hz, 2H), 3.34 (s, 2H), 4.99 (dt, J=10.0, 0.8 Hz, 1H), 5.07 (dd, J=17.2, 2.0 Hz, 1H), 5.10-5.46 (m, 1H), 7.19-7.32 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 41.4, 48.8, 51.6, 118.0, 126.3, 128.3, 128.4, 134.9, 146.5.
  • Figure US20120190854A1-20120726-C00036
  • 4-Methyl-2,2-diphenylpent-4-en-1-amine was prepared according to Molander, G. A. et al. J. Org. Chem. 63, 8983, 1998. 1H NMR (400 MHz, CDCl3) δ 0.87 (s, 2H), 1.07 (s, 3H), 2.93 (s, 2H), 3.42 (s, 2H), 4.60 (d, J=0.8 Hz, 1H), 4.83 (t, J=2.0 Hz, 1H), 7.17-7.30 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 24.6, 44.2, 48.0, 51.5, 115.5, 126.3, 128.2, 128.6, 143.1, 147.2.
  • Figure US20120190854A1-20120726-C00037
  • 2,2-Diphenylhex-5-en-1-amine was prepared according to Kondo, T. et al. J. Am. Chem. Soc. 124, 186, 2002. 1H NMR (400 MHz, CDCl3) δ 0.82 (s, 2H), 1.76-1.82 (m, 2H), 2.21-2.25 (m, 2H), 3.36 (s, 2H), 4.92-5.01 (m, 2H), 5.74-5.83 (m, 1H), 7.19-7.33 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 28.8, 36.0, 49.3, 52.0, 114.6, 126.3, 128.3, 128.5, 139.1, 146.6.
  • Figure US20120190854A1-20120726-C00038
  • (1-Allylcyclohexyl)methanamine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. 1H NMR (400 MHz, CDCl3) δ 0.94 (s, 2H), 1.16-1.38 (m, 11H), 2.01 (d, J=7.6 Hz, 2H), 2.45 (s, 2H), 4.96 (s, 1H), 5.00 (d, J=6.4 Hz, 1H), 5.68-5.77 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.7, 26.6, 33.4, 37.2, 40.0, 49.0, 117.0, 135.2.
  • Figure US20120190854A1-20120726-C00039
  • N-methyl-2,2-diphenylpent-4-en-1-amine was prepared according to Stubbert, B. D. et al. J. Am. Chem. Soc. 129, 4253, 2007. 1H NMR (400 MHz, CDCl3) δ 0.49 (s, 1H), 2.38 (s, 3H), 3.01 (d, J=6.8 Hz, 2H), 3.18 (s, 2H), 4.95-5.08 (m, 2H), 5.35-5.45 (m, 1H), 7.19-7.32 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 37.5, 42.1, 50.3, 58.9, 117.9, 126.2, 128.2, 128.3, 135.1, 146.9.
  • Figure US20120190854A1-20120726-C00040
  • N-(Cyclohexylmethyl)-2,2-diphenylpent-4-en-1-amine was prepared from 2,2-diphenylpent-4-enylamine and cyclohexanecarboxaldehyde according to the procedure used for preparation of N-benzyl-2,2-diphenylpent-4-en-1-amine. The product was obtained in a 97% yield as a colorless oil. The compound was purified by column chromatography on silica gel (Hexane/Ethyl acetate=8/1). 1H NMR (400 MHz, CDCl3) δ 0.41 (s, 1H), 0.74-0.83 (m, 2H), 1.08-1.41 (m, 4H), 1.59-1.71 (m, 5H), 2.38 (d, J=6.8 Hz, 2H), 3.05 (d, J=6.8 Hz, 2H), 3.20 (s, 2H), 4.97 (dt, J=10.4, .12 Hz, 1H), 5.06 (dt, J=16.8, 1.2 Hz, 1H), 5.36-5.47 (m, 1H), 7.19-7.33 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 26.3, 27.1, 31.6, 37.7, 41.9, 50.4, 56.3, 57.5, 117.8, 126.1, 128.2, 123.3, 135.3, 147.3.
  • Figure US20120190854A1-20120726-C00041
  • N-Benzyl-2,2-diphenylpent-4-en-1-amine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 98% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.00 (s, 1H), 3.09 (d, J=7.2 Hz, 2H), 3.25 (s, 2H), 3.77 (s, 2H), 4.95 (dt, J=10.0, 0.12 Hz, 1H), 5.04 (dt, J=16.0, 1.2 Hz, 1H), 5.34-5.45 (m, 1H), 7.19-7.35 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 41.9, 50.4, 54.4, 55.5, 117.9, 126.2, 127.0, 128.2, 128.3, 128.4, 128.5, 135.1, 140.9, 147.1.
  • Figure US20120190854A1-20120726-C00042
  • N-(4-Chlorobenzyl)-2,2-diphenylpent-4-en-1-amine was prepared according to Ackermann, L. et al. Org. Biomol. Chem. 5, 1975, 2007. The compound was obtained in 95% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 0.89 (s, 1H), 3.07 (d, J=7.2 Hz, 2H), 3.21 (s, 2H), 3.71 (s, 2H), 4.92-5.05 (m, 2H), 5.31-5.42 (m, 1H), 7.15-7.32 (m, 14H); 13C NMR (100 MHz, CDCl3) δ 41.8, 50.3, 53.6, 54.4, 117.9, 126.3, 128.2, 128.3, 128.6, 129.5, 132.6, 135.1, 139.4, 147.0.
  • Figure US20120190854A1-20120726-C00043
  • N-(4-methoxybenzyl)-2,2-diphenylpent-4-en-1-amine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 94% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 0.91 (s, 1H), 3.09 (d, J=7.2 Hz, 2H), 3.24 (s, 2H), 3.70 (s, 2H), 3.82 (s, 3H), 4.95 (dt, J=10.0, 1.2 Hz, 1H), 5.06 (dt, J=17.2, 1.2 Hz, 1H), 5.34-5.45 (m, 1H), 6.85-6.89 (m, 2H), 7.16-7.33 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 41.9, 50.4, 53.8, 55.4, 55.5, 113.8, 117.9, 126.2, 128.2, 128.3, 129.3, 133.1, 135.2, 147.1, 158.7.
  • Figure US20120190854A1-20120726-C00044
  • 4-[(2,2-Diphenylpent-4-enylamino)methyl]benzonitrile was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 94% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 0.96 (s, 1H), 3.06 (d, J=7.2 Hz, 2H), 3.19 (s, 2H), 3.78 (s, 2H), 4.92 (dd, J=10.4, 2.0 Hz, 1H), 4.99 (dt, J=17.6, 1.2 Hz, 1H), 5.28-5.39 (m, 1H), 7.16-7.35 (m, 12H), 7.99 (d, J=8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 41.8, 50.3, 53.9, 55.5, 110.7, 118.0, 119.4, 126.4, 128.2, 128.3, 128.7, 132.3, 135.0, 146.7, 146.8.
  • Figure US20120190854A1-20120726-C00045
  • Methyl 4-[(2,2-diphenylpent-4-enylamino)methyl]benzoate was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 92% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 0.97 (s, 1H), 3.08 (d, J=7.2 Hz, 2H), 3.21 (s, 2H), 3.79 (s, 2H), 3.92 (s, 3H), 4.93 (dd, J=10.0, 2.0 Hz, 1H), 5.03 (dt, J=16.8, 1.2 Hz, 1H), 5.30-5.39 (m, 1H), 7.17-7.32 (m, 12H), 7.99 (dd, J=7.2, 1.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 41.8, 50.3, 52.3, 54.0, 55.5, 118.0, 126.3, 128.1, 128.2, 128.3, 128.3, 128.9, 129.8, 135.0, 146.5, 146.9, 167.3.
  • Figure US20120190854A1-20120726-C00046
  • N-Benzyl-2,2-dimethylpent-4-en-1-amine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 96% yield as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 0.92 (s, 6H), 1.10 (s, 1H), 2.05 (d, J=7.5 Hz, 2H), 2.39 (s, 2H), 3.81 (s, 2H), 5.01-5.06 (m, 2H), 5.78-5.87 (m, 1H), 7.25-7.37 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 25.7, 34.6, 44.8, 54.9, 59.9, 117.0, 127.0, 128.2, 128.5, 135.9, 141.3.
  • Figure US20120190854A1-20120726-C00047
  • (1-Allylcyclohenxyl)-N-benzyl-methanamine was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 97% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.17 (s, 1H), 1.13-1.49 (m, 10H), 2.14 (d, J=7.6 Hz, 2H), 2.43 (s, 2H), 3.79 (s, 2H), 5.00-5.07 (m, 2H), 5.74-5.86 (m, 1H), 7.23-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.8, 26.7, 34.2, 36.9, 40.9, 54.9, 56.1, 116.9, 126.9, 128.2, 128.5, 135.6, 141.3.
  • Figure US20120190854A1-20120726-C00048
  • 1-{1-[(Benzylamino)methyl]-cyclohexyl}prop-2-en-1-ol was prepared according to Bender, C. F. et al. J. Am. Chem. Soc. 127, 1070, 2005. The compound was obtained in 81% yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.20-1.71 (m, 12H), 2.65 (d, J=12.4 Hz, 1H), 2.75 (d, J=12.0 Hz, 1H), 3.72 (s, 2H), 4.06 (d, J=5.2 Hz, 1H), 5.16 (dd, J=10.4, 2.0 Hz, 1H), 5.28 (d, 16.0 Hz, 1H), 5.85-5.94 (m, 1H), 7.24-7.35 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.6, 26.5, 31.5, 39.3, 54.4, 54.7, 80.4, 116.0, 127.5, 128.5, 128.7, 138.6, 139.4.
  • Figure US20120190854A1-20120726-C00049
  • N-Benzylpent-4-en-1-amine was prepared according to Gribkov, D. V. et al. Angew. Chem. Int. Ed. Engl. 43, 5542, 2004. The compound was obtained in 85% yield as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.48 (s, 1H), 1.62 (quint, J=7.5 Hz, 2H), 2.11 (q, J=7.0 Hz, 2H), 2.65 (t, J=7.0 Hz, 2H), 3.79 (s, 2H), 4.96 (dd, J=10.5, 1.0 Hz, 1H), 5.02 (dd, J=17.0, 1.5 Hz, 1H), 5.79-5.84 (m, 1H), 7.25-7.34 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 29.5, 31.8, 49.1, 54.2, 114.9, 127.1, 128.3, 128.6, 138.7, 140.7.
  • Figure US20120190854A1-20120726-C00050
  • N,4-Dimethyl-2,2-diphenylpent-4-en-1-amine was obtained from 4-methyl-2,2-diphenylpent-4-en-1-amine and ethylformate according to the procedure used for preparation of N-methyl-2,2-diphenylpent-4-en-1-amine. The product was obtained in a 90% yield as a colorless oil. The compound was purified by column chromatography on silica gel (Hexane/Ethyl acetate=5/1). 1H NMR (400 MHz, CDCl3) δ 0.47 (s, 1H), 1.09 (s, 3H), 2.37 (s, 3H), 3.01 (s, 2H), 3.25 (s, 2H), 4.61 (d, J=1.6 Hz, 1H), 4.84 (dd, J=2.8, 1.2 Hz, 1H), 7.17-7.31 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 24.7, 37.2, 44.7, 50.3, 58.0, 115.4, 126.2, 128.2, 128.4, 143.2, 147.6.
  • Figure US20120190854A1-20120726-C00051
  • (E)-N-Methyl-2,2-diphenylhex-4-en-1-amine and (Z)-N-Methyl-2,2-diphenylhex-4-en-1-amine were obtained as a mixture in 96% yield as a colorless oil, according to the procedure used for the preparation of N-methyl-2,2-diphenylpent-4-en-1-amine. The compound was purified by column chromatography on silica gel (Hexane/Ethyl acetate=5/1). 1H NMR (500 MHz, CDCl3) δ 0.76 (s, 1H), 0.93 (d, J=6.5 Hz, 0.2H),1.55 (d, J=6.5 Hz, 2.8H), 2.29 (s, 0.2H), 2.36 (s, 2.8H), 2.91 (d, J=7.0 Hz, 2H), 3.15 (s, 2H), 4.98-5.02 (m, 1H), 5.41-5.46 (m, 1H), 7.17-7.30 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 18.3, 37.5, 40.9, 50.5, 58.9, 126.1, 127.1, 128.1, 128.3, 128.4, 147.1.
  • Figure US20120190854A1-20120726-C00052
  • N-Benzyl-2,2-diphenylhex-5-en-1-amine was obtained from 2,2-diphenylhex-5-en-1-amine and benzaldehyde according to the procedure used for the preparation of N-benzyl-2,2-diphenylpent-4-en-1-amine. The compound was obtained in a 93% yield as a colorless oil. The compound was purified by column chromatography on silica gel (Hexane/Ethyl acetate=8/1). 1H NMR (400 MHz, CDCl3) δ 1.04 (s, 1H), 1.66-1.73 (m, 2H), 2.53-2.40 (m, 2H), 3.24 (s, 2H), 3.77 (s, 2H), 4.91-5.00 (m, 2H), 5.75-5.86 (m, 1H), 7.19-7.34 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 28.9, 36.5, 50.5, 54.2, 55.4, 114.4, 126.2, 127.0, 128.1, 128.2, 128.3, 128.5, 139.4, 140.9, 147.3.
  • Figure US20120190854A1-20120726-C00053
  • N-{4-[(2,2-diphenylpent-4-enylamino)methyl]benzyl-}-2,2-diphenylpent-4-en-1-amine was obtained from 2,2-diphenylpent-4-enylamine and terephthaldicarboxaldehyde according to the procedure used for the preparation of N-benzyl-2,2-diphenylpent-4-en-1-amine. The compound was obtained in a 91% yield as a colorless oil. The compound was purified by column chromatography on silica gel (Hexane/Ethyl acetate=4/1). 1H NMR (400 MHz, CDCl3) δ 0.86 (s, 2H), 3.05 (d, J=6.8 Hz, 4H), 3.20 (s, 4H), 3.70 (s, 4H), 4.90 (dd, J=12.8, 2.4 Hz, 2H), 5.00 (dt, J=17.2, 1.2 Hz, 2H), 5.31-5.38 (m, 2H), 7.12-7.28 (m, 24H); 13C NMR (100 MHz, CDCl3) δ 41.8, 50.3, 54.1, 55.5, 117.9, 126.2, 128.0, 128.2, 128.3, 135.1, 139.3, 147.1.
  • Figure US20120190854A1-20120726-C00054
  • Example 3 General Procedure for the Hydroamination of Olefins with Secondary Alkylamines (Tables 1 and 2, and FIG. 3)
  • A mixture of the aminoalkene (0.50 mmol), [Rh(COD)2]BF4 (0.012 mmol, 5.1 mg) and L2 (0.015 mmol, 5.9 mg) in 0.50 mL of dioxane was allowed to stir at the temperature and time shown in Table 2. The resulting reaction mixture was washed with brine (20 mL) and extracted twice with CH2Cl2 (20 mL). The combined CH2Cl2 fractions were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel to afford the desired product.
  • 1,2-Dimethyl-4,4-diphenylpyrrolidine (A) was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=15/1) and obtained in a 90% yield (113 mg) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.21 (d, J=5.6 Hz, 3H), 2.27 (dd, J=12.8, 7.6 Hz, 1H), 2.42 (s, 3H), 2.52-2.58 (m, 1H), 2.93 (d, J=9.7 Hz, 1H), 2.95 (dd, J=12.8, 7.6 Hz, 1H), 3.87 (d, J=9.7 Hz, 1H), 7.16-7.38 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 19.3, 40.8, 48.8, 52.9, 62.2, 70.7, 125.8, 126.1, 127.4, 127.7, 128.3, 128.5, 149.3, 151.0.
  • Figure US20120190854A1-20120726-C00055
  • 1-(Cyclohexylmethyl)-2-methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Washed first with 2% Et3N in hexane; Hexane/Ethyl acetate=20/1) and obtained in a 91% yield (152 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 0.91-1.00 (m, 2H), 1.11 (d, J=5.5 Hz, 3H), 1.21-1.32 (m, 3H), 1.52-1.55 (m, 1H), 1.71-1.78 (m, 4H), 2.05-2.17 (m, 3H), 2.53-2.58 (m, 1H), 2.63-2.67 (m, 1H), 2.82 (d, J=9.5 Hz, 1H), 2.85-2.89 (m, 1H), 3.87 (d, J=10 Hz, 1H), 7.15-7.35 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 19.9, 26.4, 26.6, 27.2, 32.1, 32.5, 37.6, 48.4, 53.0, 60.6, 61.7, 67.9, 125.6, 126.0, 127.6, 127.9, 128.1, 128.4, 149.2, 151.6; Anal. Calcd for C24H31N: C, 86.43; H, 9.37; N, 4.20 Found: C, 86.20; H, 9.67; N, 4.37.
  • Figure US20120190854A1-20120726-C00056
  • 1-Benzyl-2-methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=20/1) and obtained in a 91% yield (151 mg) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.24 (d, J=6.0 Hz, 3H), 2.80 (dd, J=12.8,7.6 Hz, 1H), 2.85 (d, J=9.4 Hz, 1H), 2.86-2.94 (m, 1H), 2.99 (dd, J=12.6 Hz, 1H), 3.31 (d, J=13.6 Hz, 1H), 3.71 (d, J=9.4 Hz, 1H), 4.16 (d, J=13.6 Hz, 1H), 7.15-7.46 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 19.8, 48.3, 52.8, 58.3, 59.9, 66.8, 125.7, 126.1, 127.1, 127.6, 127.7, 128.1, 128.4, 128.5, 129.0, 140.4, 149.0, 151.0.
  • Figure US20120190854A1-20120726-C00057
  • 1-(4-Chlorobenzyl)-2-methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=20/1) and obtained in a 99% yield (179 mg) as a white solid. 1H NMR (500 MHz, CDCl3) δ 1.24 (d, J=6.0 Hz, 3H), 2.31 (dd, J=13.0, 7.6 Hz, 1H), 2.85 (d, J=9.5 Hz, 1H), 2.87-2.93 (m, 1H), 3.00 (dd, J=13.0, 7.6 Hz, 1H), 3.30 (d, J=13.5 Hz, 1H), 3.69 (d, J=9.5 Hz, 1H), 4.11 (d, J=13.5 Hz, 1H), 7.15-7.37 (m, 14H); 13C NMR (125 MHz, CDCl3) δ 19.8, 48.2, 52.9, 57.6, 59.9, 66.7, 125.8, 126.2, 127.5, 127.7, 128.2, 128.5, 128.7, 130.2, 132.7, 139.0, 148.9, 150.7; Anal. Calcd for C24H24ClN: C, 79.65; H, 6.68; N, 3.87 Found: C, 79.55; H, 6.63; N, 3.69.
  • Figure US20120190854A1-20120726-C00058
  • 1-(4-Methoxybenzyl)-2-methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=20/1) and obtained in a 98% yield (175 mg) as a white solid. 1H NMR (400 MHz, CDCl3) δ 1.24 (d, J=5.6 Hz, 3H), 2.27 (dd, J=12.8, 7.6 Hz, 1H), 2.83 (d, J=9.6 Hz, 1H), 2.84-2.91 (m, 1H), 3.00 (dd, J=12.8, 7.6 Hz, 1H), 3.26 (d, J=13.2 Hz, 1H), 3.71 (d, J=9.6 Hz, 1H), 3.87 (s, 3H), 4.11 (d, J=13.2 Hz, 1H), 6.95 (dd, J=6.4, 2.8 Hz, 2H), 7.16-7.38 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 19.8, 48.3, 52.7, 55.5, 57.6, 59.9, 66.6, 113.9, 125.7, 126.1, 127.5, 127.7, 128.1, 128.4, 130.0, 132.3, 149.1, 151.0, 158.8; Anal. Calcd for C25H27NO: C, 83.99; H, 7.61; N, 3.92 Found: C, 83.77; H, 7.65; N, 4.02.
  • Figure US20120190854A1-20120726-C00059
  • 1-(4-Cyanobenzyl)-2-methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=15/1) and obtained in an 85% yield (150 mg) as a white solid. 1H NMR (400 MHz, CDCl3) δ 1.20 (d, J=5.6 Hz, 3H), 2.27-2.32 (m, 1H), 2.85 (d, J=9.6 Hz, 1H), 2.86-2.98 (m, 2H), 3.38 (d, J=14.0, 1H), 3.62 (d, J=9.6 Hz, 1H), 4.12 (d, J=14.0 Hz, 1H), 7.14-7.32 (m, 10H), 7.50 (d, J=8.0 Hz, 2H), 7.63 (dd, J=8.0, 1.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 19.8, 47.9, 52.9, 57.8, 59.9, 66.7, 110.8, 119.4, 125.9, 126.2, 127.3, 127.6, 128.2, 128.5, 129.3, 132.4, 146.4, 148.6, 150.4; Anal. Calcd for C25H24N2: C, 85.19; H, 6.86; N, 7.95 Found: C, 85.14; H, 6.82; N, 7.99.
  • Figure US20120190854A1-20120726-C00060
  • Methyl 4-(2-methyl-4,4-diphneylpyrrolidin-1-ylmethyl)-benzoate was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=10/1) and obtained in a 94% yield (181 mg) as a white solid. 1H NMR (400 MHz, CDCl3) δ 1.22 (d, J=6.0 Hz, 3H), 2.28 (dd, J=12.4, 7.6 Hz, 1H), 2.83 (d, J=10.0 Hz, 1H), 2.88-2.99 (m, 2H), 3.35 (d, J=13.6 Hz, 1H), 3.66 (d, J=9.6 Hz, 1H), 3.95 (s, 3H), 4.14 (d, J=13.6, 1H), 7.14-7.32 (m, 10H), 7.49 (d, J=8.4 Hz, 2H), 8.06 (d, J=8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 19.8, 48.1, 52.3, 52.8, 58.0, 60.1, 66.7, 125.8, 126.2, 127.4, 127.6, 128.2, 128.5, 128.7, 129.0, 129.9, 146.0, 148.8, 150.6, 167.4; Anal. Calcd for C26H27NO2: C, 81.01; H, 7.06; N, 3.63 Found: C, 80.93; H, 7.02; N, 3.75.
  • Figure US20120190854A1-20120726-C00061
  • 1-Benzyl-2,4,4-trimethylpyrrolidine was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=20/1) and obtained in an 83% yield (84 mg) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.00 (s, 3H), 1.10 (s, 3H), 1.18 (d, J=6.0 Hz, 3H), 1.35 (dd, J=12.4 Hz, 1H), 1.74 (dd, J=12.4, 3.6 Hz, 1H)1.96 (d, J=9.2 Hz, 1H), 2.52-2.68 (m, 1H), 2.67 (d, J=9.2 Hz, 1H), 3.13 (d, J=12.8 Hz, 1H), 4.05 (d, J=12.8 Hz 1H), 7.23-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 19.7, 29.5, 30.9, 35.6, 49.3, 58.3, 60.0, 68.6, 126.8, 128.3, 128.9, 140.3.
  • Figure US20120190854A1-20120726-C00062
  • 2-Benzyl-3-methyl-2-aza-spiro[4,5]decane was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=20/1) and obtained in a 92% yield (112 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.17 (d, J=6.0 Hz, 3H), 1.28-1.47 (m, 11H), 1.77 (dd, J=12.5, 7.6 Hz, 1H), 1.89 (d, J=9.5 Hz, 1H), 2.48-2.53 (m, 1H), 2.80 (d, J=9.0 Hz, 1H), 3.11 (d, J=13.0 Hz, 1H), 4.04 (d, J=13.5 Hz, 1H), 7.23-7.36 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 19.5, 23.7, 23.8, 26.3, 38.7, 39.4, 39.5, 47.1, 58.2, 59.2, 66.9, 126.8, 128.3, 128.9, 140.2.
  • Figure US20120190854A1-20120726-C00063
  • 2-Benzyl-3-methyl-4-hydroxyl-2-aza-spiro[4,5]decane was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=5/1) and obtained in a 65% yield (84 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.20 (d, J=6.0 Hz, 3H), 1.28-1.56 (m, 10), 1.93 (d, J=9.5 Hz, 1H), 1.99 (d, J=11.0 Hz, 1H), 2.67-2.70 (m, 1H), 2.75 (d, J=9.5 Hz, 1H), 3.12 (d, J=13.0 Hz, 1H), 3.52 (dd, J=11.0, 3.5 Hz, 1H), 4.00 (d, J=13.5 Hz, 1H), 7.24-7.32 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 13.7, 23.3, 23.9, 26.1, 32.4, 37.8, 43.9, 57.5, 62.2, 64.4, 81.4, 127.0, 128.4, 128.9, 139.5.
  • Figure US20120190854A1-20120726-C00064
  • 1-Benzyl-2-methylpyrrolidine was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=20/1) and obtained in a 64% yield (56 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.21 (d, J=6.0 Hz, 3H), 1.48-1.54 (m, 1H), 1.64-1.68 (m, 1H), 1.71-1.76 (m, 1H), 1.92-1.98 (m, 1H), 2.14 (q, J=9.0 Hz, 1H), 2.41-2.46 (m, 1H), 2.94 (td, J=9.0, 3.0 Hz, 1H), 3.19 (d, J=13.0 Hz, 1H), 4.05 (d, J=12.5 Hz, 1H), 7.24-7.36 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 19.2, 21.7, 32.9, 54.2, 58.5, 59.9, 127.1, 128.4, 129.4, 139.3.
  • Figure US20120190854A1-20120726-C00065
  • 1,2,2-Trimethyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=20/1) and obtained in a 96% yield (121 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.74 (s, 6H), 2.44 (s, 3H), 2.71 (s, 2H), 3.60 (s, 2H), 7.27 (t, J=7.5 Hz, 2H), 7.36-7.45 (m, 8H); 13C NMR (125 MHz, CDCl3) δ 24.6, 34.6, 52.1, 54.7, 60.6, 67.6, 125.9, 127.5, 128.4, 150.4.
  • Figure US20120190854A1-20120726-C00066
  • 2-Ethyl-1-methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=20/1) and obtained in a 76% yield (96 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 0.92 (t, J=7.5 Hz, 3H), 1.26-1.33 (m, 1H), 1.72-1.77 (m, 1H), 2.23-2.38 (m, 2H), 2.39 (s, 3H), 2.87-2.92 (m, 2H), 3.84 (d, J=9.5 Hz, 1H), 7.12-7.35 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 11.1, 26.8, 41.2, 45.8, 52.8, 68.5, 70.4, 125.7, 126.1, 127.4, 127.6, 128.3, 128.4, 149.3, 150.8.
  • Figure US20120190854A1-20120726-C00067
  • 1-Benzyl-2-methyl-5,5-diphenylpiperidine was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=20/1) and obtained in an 86% yield (147 mg) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.26 (d, J=6.0 Hz, 3H), 1.46-1.56 (m, 1H), 1.71-1.78 (m, 1H), 2.31 (td, J=12.0, 3.2 Hz, 1H), 2.53-2.62 (m, 3H), 3.25 (d, J=13.2 Hz, 1H), 3.49 (d, J=12.4 Hz, 1H), 4.19 (d, J=13.2 Hz, 1H), 7.19-7.51 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 19.2, 31.3, 34.6, 46.9, 56.5, 59.2, 61.3, 125.7, 126.0, 127.3, 127.4, 128.0, 128.3, 128.4, 128.8, 129.9, 139.8, 147.1, 148.9.
  • Figure US20120190854A1-20120726-C00068
  • 1-{4-[(2-Methyl-4,4-diphenylpyrrolidin-1-yl)methyl]benzyl}-2-methyl-4,4-diphen-ylpyrrolidine, which was provided as a 1:1 mixture of diastereomers (according to 13C spectrum), was purified by flash chromatography on silica gel (Hexane/Ethyl acetate=5/1) and obtained in a 98% yield (282 mg) as a white solid. 1H NMR (500 MHz, CDCl3) δ 1.25 (d, J=6.0 Hz, 6H), 2.28 (dd, J=13.0, 8.0 Hz, 2H), 2.84-2.90 (m, 4H), 2.99 (dd, J=13.0, 8.0 Hz, 2H), 3.31 (d, J=13.5 Hz, 2H), 3.74 (d, J=10.0 Hz, 2H), 4.16 (d, J=14.0 Hz, 2H), 7.16-7.40 (m, 24H); 13C NMR (125 MHz, CDCl3) δ 19.8, 48.3, 48.4, 52.7, 58.0, 58.1, 59.9, 66.7, 66.8, 125.7, 126.1, 127.5, 127.6, 127.8, 128.1, 128.4, 128.7, 128.8, 138.8, 138.9, 149.1, 150.9, 151.0; Anal. Calcd for C42H44N2: C, 87.45; H, 7.69; N, 4.86 Found: C, 87.43; H, 7.86; N, 5.02.
  • Figure US20120190854A1-20120726-C00069
  • Example 4 General Procedure for the Hydroamination of Olefins with Primary Alkylamines (Table 3)
  • A mixture of the aminoalkene (0.50 mmol), [Rh(COD)2]BF4 (0.025 mmol, 10.0 mg) and L2 (0.030 mmol, 12.0 mg) in 0.50 mL of dioxane was allowed to stir at the temperature and time shown in Table 3. The resulting reaction mixture was washed with brine (20 mL) and extracted with CH2Cl2 (20 mL) twice. The combined CH2Cl2 fractions were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel to afford the desired product.
  • 2-Methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=5/1) and obtained in an 83% yield (98 mg) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.22 (d, J=6.5 Hz, 3H), 1.97 (s, 1H), 2.28 (dd, J=13.0, 9.0 Hz, 1H), 2.82 (dd, J=13.0, 6.5 Hz, 1H), 3.36-3.41 (m, 1H), 3.49 (d, J=11.5 Hz, 1H), 3.67 (dd, J=11.5, 1.5 Hz, 1H), 7.16-7.34 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 22.7, 47.3, 53.3, 57.5, 58.1, 126.2, 126.3, 127.2, 127.3, 128.5, 128.6, 147.4, 148.1.
  • Figure US20120190854A1-20120726-C00070
  • 2-Methyl-5,5-diphenylpiperidine was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=5/1) and obtained in an 85% yield (107 mg) as a slightly yellow oil. 1H NMR (500 MHz, CDCl3) δ 1.02 (d, J=6.5 Hz, 3H), 1.12-1.21 (m, 1H), 1.32 (s, 1H), 1.65 (dq, J=13.0, 3.5 Hz, 1H), 2.23 (td, J=13.0, 4.0 Hz, 1H), 2.72 (dq, J=13.0, 3.5 Hz, 1H), 2.76-2.81 (m, 1H), 3.13 (d, J=14.0 Hz, 1H), 3.92 (dd, J=13.5, 3.0 Hz, 1H), 7.11-7.26 (m, 6H), 7.36 (t, J=8.0 Hz, 2H), 7.43 (dd, J=8.5, 1.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 22.7, 31.6, 35.6, 45.4, 52.5, 56.1, 126.0, 126.1, 126.7, 128.4, 128.5, 128.9, 145.0, 149.1.
  • Figure US20120190854A1-20120726-C00071
  • 2,2-Methyl-4,4-diphenylpyrrolidine was purified by flash chromatography on silica gel (washed with 2% Et3N in hexane first, Hexane/Ethyl acetate=5/1) and obtained in a 96% (120 mg) yield as a slightly yellow solid. 1H NMR (400 MHz, CDCl3) δ 1.18 (s, 6H), 2.10 (s, 1H), 2.57 (s, 2H), 3.67 (s, 2H), 7.14-7.19 (m, 2H), 7.26-7.34 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 31.0, 52.3, 57.4, 58.6, 59.6, 126.2, 127.2, 128.7, 147.8.
  • Figure US20120190854A1-20120726-C00072
  • 2,3-Dimethyl-2-aza-spiro[4,5]decane was obtained in a 74% NMR yield by using trimethoxybenzene as internal standard. 1H NMR (500 MHz, CDCl3) δ 1.08 (dd, J=13.0, 9.5 Hz, 1H), 1.19 (d, J=6.0 Hz, 3H), 1.40-1.43 (m, 10H), 1.81 (dd, J=12.5, 6.5 Hz, 1H), 2.67 (d, J=11.0 Hz, 1H), 2.84 (d, J=11.5 Hz, 1H), 3.12 (s, 1H), 3.22-3.27 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 21.1, 23.7, 24.8, 26.2, 29.9, 37.2, 38.6, 44.0, 54.4, 58.5.
  • Figure US20120190854A1-20120726-C00073
  • While various embodiments of the invention have been described, it will be apparent to those of ordinary skill in the art that other embodiments and implementations are possible within the scope of the invention. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.

Claims (19)

1. A method, comprising:
reacting an amino group, a composition comprising rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture;
Figure US20120190854A1-20120726-C00074
where R1 is an organic group comprising a sp3 carbon atom bonded to CA,
R2 is selected from the group consisting of hydrogen, methyl, and an organic group comprising a sp3 carbon atom bonded to CA, and
R3 and R4 independently are selected from the group consisting of hydrogen, methyl, and an organic group comprising a sp3 carbon atom bonded to CB; and
forming a hydroaminated product in the reaction mixture.
2. The method of claim 1, where the amino group is a substituent group of the substrate.
3. The method of claim 2, where the hydroaminated product comprises a heterocyclic ring comprising a nitrogen from the amino group and at least one of CA and CB.
4. The method of claim 1, where the amino group is a substituent group of a compound separate from the substrate.
5. The method of claim 1, where the amino group is a primary amino group.
6. The method of claim 1, where the amino group is a secondary amino group.
7. The method of claim 1, where the substrate comprises at least one functional group.
8. The method of claim 7, where the at least one functional group is selected from the group consisting of hydroxyl, ether, ester, cyano, and halogen.
9. The method of claim 1, where R2 is methyl or an organic group comprising a sp3 carbon atom bonded to CA.
10. The method of claim 1, where at least one of R3 and R4 is methyl or an organic group comprising a sp3 carbon atom bonded to CB.
11. The method of claim 1, where the organic ligand is selected from the group consisting of DPPF, t-BuXantphos, 4,5-(bis[bis-diethylamido]-phosphonito)-9,9-dimethylxanthene, 2-dicyclohexyl-phosphino-2′-(N,N-dimethylamino)biphenyl and substituted derivatives thereof.
12. The method of claim 1, where the mole ratio of ligand to rhodium is from 0.8 to 2.
13. The method of claim 1, where the mole ratio of ligand to rhodium is from 0.9 to 1.5.
14. The method of claim 1, where the mole ratio of ligand to rhodium is from 1 to 1.2.
15. The method of claim 1, where
when the catalyst is present in the reaction mixture in an amount providing 2.5 mol % rhodium relative to the amino group, and
the reaction mixture is heated at 70° C. for 7 h,
the yield of the hydroaminated product in the reaction mixture is at least 65%.
16. The method of claim 15, where the yield of the hydroaminated product in the reaction mixture is at least 70%.
17. The method of claim 15, where the yield of the hydroaminated product in the reaction mixture is at least 75%.
18. The method of claim 15, where the yield of the hydroaminated product in the reaction mixture is at least 80%.
19. The method of claim 15, where the yield of the hydroaminated product in the reaction mixture is at least 90%.
US13/440,465 2007-10-12 2012-04-05 Hydroamination of Alkenes Abandoned US20120190854A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/440,465 US20120190854A1 (en) 2007-10-12 2012-04-05 Hydroamination of Alkenes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97965207P 2007-10-12 2007-10-12
US12/251,062 US8188302B2 (en) 2007-10-12 2008-10-14 Hydroamination of alkenes
US13/440,465 US20120190854A1 (en) 2007-10-12 2012-04-05 Hydroamination of Alkenes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/251,062 Division US8188302B2 (en) 2007-10-12 2008-10-14 Hydroamination of alkenes

Publications (1)

Publication Number Publication Date
US20120190854A1 true US20120190854A1 (en) 2012-07-26

Family

ID=40754128

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/251,062 Active 2030-08-30 US8188302B2 (en) 2007-10-12 2008-10-14 Hydroamination of alkenes
US13/440,465 Abandoned US20120190854A1 (en) 2007-10-12 2012-04-05 Hydroamination of Alkenes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/251,062 Active 2030-08-30 US8188302B2 (en) 2007-10-12 2008-10-14 Hydroamination of alkenes

Country Status (1)

Country Link
US (2) US8188302B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104496875A (en) * 2014-12-12 2015-04-08 常州大学 Synthesis method of 2-allyl-2-formaldehyde-N-phenyl pyrroline
DE102016224089A1 (en) 2016-12-05 2018-06-07 Clariant International Ltd Amine derivatives of β-Farnesens

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188302B2 (en) * 2007-10-12 2012-05-29 The Board Of Trustees Of The University Of Illinois Hydroamination of alkenes
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156824A1 (en) * 2007-10-12 2009-06-18 Board Of Trustees Of University Of Illinois Hydroamination of Alkenes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307087B1 (en) * 1998-07-10 2001-10-23 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
US6395916B1 (en) * 1998-07-10 2002-05-28 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
US6384282B2 (en) * 2000-03-01 2002-05-07 Yale University Transition metal-catalyzed process for addition of amines to carbon-carbon double bonds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156824A1 (en) * 2007-10-12 2009-06-18 Board Of Trustees Of University Of Illinois Hydroamination of Alkenes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Liu et al. J. Am. Chem. Soc. 2008, 130, 1570-1571 *
Takemiya et al. J. Am. Chem. Soc. 2006, 128, 6042-6043 *
Utsunomiya et al. J. Am. Chem. Soc. 2003, 125, 5808-5809 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104496875A (en) * 2014-12-12 2015-04-08 常州大学 Synthesis method of 2-allyl-2-formaldehyde-N-phenyl pyrroline
DE102016224089A1 (en) 2016-12-05 2018-06-07 Clariant International Ltd Amine derivatives of β-Farnesens
WO2018104176A1 (en) 2016-12-05 2018-06-14 Clariant International Ltd Amine derivatives of the beta-farnesene

Also Published As

Publication number Publication date
US20090156824A1 (en) 2009-06-18
US8188302B2 (en) 2012-05-29

Similar Documents

Publication Publication Date Title
US7230134B2 (en) Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions
US8835691B2 (en) Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
RU2593994C2 (en) Method for direct amination of secondary alcohols using ammonia to primary amines
US8946463B2 (en) Process for the direct amination of alcohols using ammonia to form primary amines by means of a xantphos catalyst system
Borszeky et al. Enantioselective Hydrogenation of α, β-Unsaturated Carboxylic Acids over Cinchonidine Modified Palladium: Nature of Modifier–Reactant Interaction
EP1202952B2 (en) Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds
US20100197976A1 (en) Catalysts
US10550139B2 (en) Polydentate ligands and their complexes for molecular catalysis
US20120190854A1 (en) Hydroamination of Alkenes
EP3301087A1 (en) Process for preparing chiral amines
JP2021509684A (en) Manganese-catalyzed hydrogenation of esters
EP3421455B1 (en) Improved process for the preparation of chiral 3-amino-piperidins, useful intermediates for the preparation of tofacitinib
Periasamy et al. Synthesis of Amines by Reduction of Imines with the MCl2/NaBH4 (M= Co, Ni) System
Petricci et al. Microwave assisted hydroaminomethylation of alkenes
Thangavel et al. Syntheses and structural investigations of new half sandwich Ir (III) and Rh (III) amine compounds and their catalytic transfer hydrogenation of aromatic ketones and aldehydes in water
JP2021514933A (en) Hydrogenation of imine in RU complex
Hofmann New Dehydrogenative Coupling Reactions and Borrowing Hydrogen Processes Using Iron and Manganese Catalysts
JPH06135906A (en) Method for racemizing optically active diamine
Ickes The development of a rhodium-catalyzed chemo-and stereoselective hydroamination for the synthesis of 1, 2-diamines
JP4310511B2 (en) Method for producing aminomethylpyridine
JP2022516764A (en) Its use in hydrogenation of manganese catalysts and ketones
General Supporting Information Highly Enantioselective Cyclization of 5-Alkynals through Rhodium-Catalyzed Asymmetric Hydroacylation
Tillack et al. Rhodium-Catalyzed Amination of Aromatic Olefins
Morris Synthetic Strategies for Enhancing Metal-ligand Cooperation and Enantioselective Polar Bond Hydrogenation with Base Metal Catalysts

Legal Events

Date Code Title Description
AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN;REEL/FRAME:028156/0755

Effective date: 20120427

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION